Related Experiment Video
Updated: Jan 19, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
[The problem of insomnia in infant/young children: issues of diagnosis and treatment]
L G Khachatrian1, M S Pogorelova2, N A Geppe1
1Sechenov First Moscow State Medical University, Moscow, Russia.
Insights
Dormikind significantly improved sleep initiation and duration in young children with sleep disorders. This natural remedy demonstrated superior efficacy and safety compared to behavioral therapy for pediatric sleep issues.
Area of Science:
- Pediatrics
- Sleep Medicine
- Pharmacology
Background:
- Sleep disorders are prevalent in infants and young children.
- Effective and safe treatment options are crucial for pediatric sleep health.
- Dormikind is a homeopathic preparation used for sleep disturbances.
Purpose of the Study:
- To evaluate the efficacy and safety of dormikind in treating sleep and sleep initiation disorders in young children.
- To compare the effects of dormikind with behavioral therapy.
Main Methods:
- A study involving 114 patients aged 6 months to 2.5 years with sleep disorders.
- Patients were divided into two groups: 64 received dormikind, and 50 received behavioral therapy for 28 days.
Main Results:
- Dormikind significantly reduced sleep initiation time (26.2±4.8 minutes) and improved sleep patterns compared to behavioral therapy.
- Children treated with dormikind showed a significant increase in falling asleep in their own beds and improved emotional-behavioral states.
- Dormikind demonstrated a higher efficacy in improving sleep duration and reducing nighttime awakenings.
Conclusions:
- Dormikind is a highly effective and safe treatment for sleep and sleep initiation disorders in infants and young children.
- The study confirms the positive impact of dormikind on sleep quality and behavioral outcomes.
- Dormikind offers a beneficial alternative for managing pediatric sleep disturbances.
Objective:
To obtain further evidence of the efficacy of dormikind in infant/young children.
Material And Methods:
The study was performed in the group of 114 patients, aged 6 months to 2.5 years, with sleep and sleep initiation disorders. Sixty-four patients received treatment with dormikind (group 1) and 50 patients received behavioral therapy (group 2) for 28 days.
Results And Conclusion:
In group 1, sleep initiation decreased by 1.7 times and reached 26.2±4.8 minutes, the number of children sleeping on hands dropped by 8.7 times and sleeping in the parent's bed by 2 times. In group 2, the same characteristics changed by 1.1, 1.3 and 1.5 times, respectively, and sleep initiation reached 33.4±2.9 minutes. The number of patients of group 1 falling asleep in their own beds increased by 3.2 times vs 1.2 times in group 2. Duration of night sleep increased and frequency of awakening reduced as well. The significant positive dynamics was noted in the emotional-behavior state of children after therapy: the total score significantly improved by 2.9 times to the end of treatment compared to group 2 (by 1.3 times). IMOS score showed significant difference between the groups on «total recovery» and «significant improvement». Therefore, the high efficacy and safety of dormikind in children have been confirmed.
Related Concept Videos
Management of Insomnia
Insomnia
Multiple factors contribute...
Nightmares and Night Terrors
Nightmares...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
CNS Depressants: Barbiturates and Benzodiazepines

